San Francisco Facial Recognition Ban

Wouldn’t you want to shorten the amount of time it takes to go through an airport, or allow concert venues to spot out possible dangerous people, or access a safe with only your face like in the movies? Airports, banks, Walmart, and even our own phones use facial recognition software for identification and security. With this technology that seemingly safeguards our most important information, why has the city of San Francisco banned it?

There are about 50 million surveillance cameras around the US in addition to the millions of cameras we all carry in our pockets (1). With the advancement of technology’s capacities and impacts, those cameras can turn into devices used for facial recognition. Facial recognition software can use video, photos, and real-time footage to detect a face, extract/translate those features into code to be compared to find a match. The databases used to compare the facial recognition software’s findings can come from voluntarily submitted photos users upload for security purposes. Software can also be used for comparing mugshots, driver’s license photos and passport photos. According to the Georgetown Center for Privacy and Law, approximately 117 million people’s photos are included in facial recognition databases (2).

The biggest user of facial recognition software is the government. Law enforcement agencies use facial recognition software for surveillance to find suspects in a crime and track down crime victims. Another example of police use of the technology was in 2015 to find and arrest protesters in Baltimore after the death of Freddie Grey (3). This use of facial recognition software was criticized for impeding on people’s First Amendment right to protest.

In 2019, San Francisco became the first city in the world to ban facial recognition software for local public entities. “It shall be unlawful for any Department to obtain, retain, access, or use: 1) any Face Recognition Technology; or 2) any information obtained from Face Recognition Technology”. The ban only reaches city government agencies, including the San Francisco Police Department (4). The ban does not apply to state and federal government agencies operating within the city, as well as private entities such as Facebook, Apple, and banking institutions.

San Francisco’s decision to ban the technology for local law enforcement agencies was to counteract the many issues with the technology, and its impact on certain communities. The provision cites inequalities in surveillance technology and their impact on civil liberties and civil rights. The bill’s sponsor, Aaron Peskin said its purpose is to “keep law enforcement from a burgeoning technology that has been blamed for inaccuracies — particularly when it comes to identifying minorities — and is largely unregulated in the United States.” (5)

In the case of Baltimore using facial recognition software to identify and arrest protesters after the death of Freddie Grey, a vast majority of the protesters were African-American, and they were exercising their right to protest after a police shooting of an unarmed black man. Many felt the use of the technology was another way for police to encroach on an already marginalized community and continue the breakdown of trust between the police and that community.

The technology itself has issues that impact certain communities. The software has many troubles with the recognition of women and people of color. MIT researcher, Joy Buolamwini, works on the issues with facial recognition software, particularly its weaknesses recognizing women and people of color. Her testing of different facial recognition software finished with 1% of error when identifying white men, but 30% of error identifying women of color (2). The programs also have problems properly identifying transgender people. These misidentifications from facial recognition software have serious, real-life consequences, including incarceration, deportation, and even death.

There are also many concerns with police departments’ use of the technology. Facial recognition software works best when comparing high quality photos with the correct lighting. Unfortunately, many police departments may not have access to those quality photos when searching for a suspect, so they use what they have access to, including sketches and celebrity look-a-likes (2). The technology cannot work properly for policing if these are the images used to identify an individual.

The main problem with facial recognition software and its infringement of civil liberties is that the technology is used without consent and without the need for probable cause. The 4th amendment requires probable cause for a warrant to be issued in order to search a person or their property. A person’s face falls under that guideline, yet there are no regulations as to when/for what reason law enforcement agencies can use facial recognition.

An example of how far facial recognition software could go in relation to civil liberties is China. China is one of the biggest implementers of facial recognition software. The government monitors citizens through some 170 million CCTV cameras. In China, facial recognition software enables citizens to withdraw money, check in at the airport, and pay for goods all with the scan of their face. Though much of the technology is used to streamline daily tasks, the technology is also used for intense surveillance by the Chinese government, recently being implemented in the persecution of muslim minorities. (6)

Law enforcement agencies have pushed back on the San Francisco ban, citing the technology’s use for better policing by using software instead of looking through hundreds of mugshot books in order to identify a suspect. It was useful for the FBI in 2014 when identifying a fugitive living in Nepal (7). It can also be useful for government agencies when identifying disaster victims, helping to inform and unify families (8). Though many law enforcement agencies argue for using facial recognition, many understand the negative impacts of the technology and welcome regulation and even a moratorium until the issues relating to misidentification can be resolved.

Many of the issues with facial recognition can be solved over time, including teaching the software to better identify women, people of color, and transgender people with more diverse data sets and more people from those communities contributing to the technology’s creation. There should be more regulation of the technology, including requiring consent and probable cause. Policing with facial recognition cannot be 100% effective unless departments create policies that dictate what types of images are being fed into the software and requiring more evidence to prove a person’s guilt. Facial recognition can be a great supplementive tool for convictions, but it should not be the sole form of obtaining evidence.

In addition to San Francisco, other governments in the US and around the world have also begun the process of regulating facial recognition software, but none to the extent of San Francisco’s ban. In 2008, Illinois passed the Biometric Information Privacy Act, which requires private entities to obtain explicit consent from the consumer before using their biometric data (including their face) (9). Illinois’ law only pertains to private entities and does not apply to the government. This law was used as a reference for the European Union’s General Data Protection Regulation (GDPR) which also prohibits the processing of personal data (genetic data and biometric data) unless “the data subject has given explicit consent to the processing of those personal data for one or more specified purposes”(10)

Oakland and the state of Massachusetts both have bills in the works, similar to San Francisco, that would ban the use of facial recognition software by government officials. A bill introduced to Congress by Senators Roy Blunt (R-MO) and Brian Schatz (D-HI) would also regulate the use of facial recognition software on a federal level.(Citation)

There are a number of unknowns with this new technology and San Francisco’s ban is just the start to a global conversation on the uses and impacts of facial recognition. I will be keeping an eye out for new developments and forthcoming legislation relating to it. Governments need to catch up to ever growing and evolving technology and the impact on citizens’ lives.

 

 

 

References:

1. Gonzalez, Oscar. “Millions of Surveillance Cameras Could Become AI Security Guards, ACLU Warns.” CNET, CNET, 13 June 2019, www.cnet.com/news/millions-of-surveillance-cameras-could-become-ai-security-guards-aclu-warns/

2. Clare Garvie et al., “The Perpetual Line-Up: Unregulated Police Face Recognition in America,” Center on Privacy & Technology, Georgetown Law, Oct. 18, 2016

3. Facial Recognition Technology- Hearing before Oversight and Reform Committee. House of Representatives, 116th Congress (2019)

4. San Francisco Board of Supervisors, Administrative Code – Acquisition of Surveillance Technology. 190110, Enacted 7/1/2019

5. Thadani, Trisha. “SF Could Ban Facial Recognition Software – Opinion Is Divided over Whether That’s Good.” SFChronicle.com, San Francisco Chronicle, 14 May 2019, www.sfchronicle.com/politics/article/SF-could-ban-facial-recognition-software-13842657.php.

6. The Economist, director. China: Facial Recognition and State Control | The Economist. YouTube, YouTube, 24 Oct. 2018, www.youtube.com/watch?v=lH2gMNrUuEY.

7. “Long-Time Fugitive Neil Stammer Captured.” FBI, FBI, 12 Aug. 2014, www.fbi.gov/news/stories/long-time-fugitive-neil-stammer-captured.

8. Broach, John, et al. “Use of Facial Recognition Software to Identify Disaster Victims With Facial Injuries.” Disaster Medicine and Public Health Preparedness, vol. 11, no. 5, 2017, pp. 568–572., doi:10.1017/dmp.2016.207.

9. Illinois General Assembly, Civil Liabilities: Biometric Information Privacy Act. (740 ILCS 14/) 2009

10. EU General Data Protection Regulation (GDPR): Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016. Chapter II Article 9.

11. United States. Cong. Senate. Commercial Facial Recognition Privacy Act of 2019. 116th Cong. S.847.

Osborne for The Washington Post, “‘Privatization’ doesn’t make charter schools bad. It makes them like Obamacare and Medicare.”

When Sen. Bernie Sanders (I-Vt.) recently unveiled his education reform plan, it predictably castigated charter schools, claiming that they were “privatizing public schools.” Sanders joined a long line of leaders who tar charters with the privatization brush. Before, during and after the Los Angeles teachers strike last winter, union President Alex Caputo-Pearl did so repeatedly. “The charter school movement,” he declared, is “a vehicle for billionaires to privatize the system and undermine the public district.”

His teachers constantly repeated the charge. Even Rep. Alexandria Ocasio-Cortez (D-N.Y.), who represents the Bronx and part of Queens, threw in her two cents, tweeting in support of “these LA teachers striking against privatization.”

National union leaders Randi Weingarten of the American Federation of Teachers and Lily Eskelsen García of the National Education Association regularly add to the chorus. From the picket line in Los Angeles, Eskelsen García went so far as to announce that “the billionaires who are behind this [chartering], the venture capitalists, the Wall Street guys, are out to make money on public schools.” (For the record, California outlawed for-profit charters last year.) And in the District of Columbia, Washington Teachers’ Union leaders raised the issue against Chancellor Lewis D. Ferebee during his nomination hearings. “My real concern here is privatization of public education,” Washington Teachers’ Union executive board member Signe Nelson told the D.C. Council.

Continue reading at The Washington Post.

The Economic Implications of State-Based Chemical Regulation: Two Approaches

We are seeing two important, and in some ways, potentially contradictory trends in manufacturing these days. On the one hand, there are signs of a transformation and rebirth in domestic manufacturing. Technological innovations such as 3D printing and robotics are lowering the cost of manufacturing at home, while global trade tensions are leading companies to shorten their supply chains (1). This raises the possibility of a new round of job creation in local domestic manufacturing.

At the same time, states are increasingly moving to tighten their oversight and regulation of chemicals, especially those in consumer products. For example, the state of Washington just adopted “The Pollution Prevention for Our Future Act,” billed as the strongest such measure in the country. The New York State legislature has recently passed legislation regulating chemicals in children’s products. In the same vein, Vermont’s legislature just passed a bill strengthening and broadening existing rules for disclosure of chemicals in children’s products.

Increased attention to safety is not a bad thing. We can have innovation and safety in manufacturing, while still encouraging growth and jobs.

But let’s be honest: state governments do not have the budgetary resources to assess the risk of hundreds of chemicals. As a result, state regulators and legislatures are reaching out globally and relying on lists of chemicals assembled by highly trusted authorities around the world, in addition to any information from the U.S. federal government. For example, in the U.S., states such as Maine, Minnesota, and California, among others, have relied on the E.U.’s conclusions about certain chemicals when crafting their Chemicals of Concern lists, which prioritize chemicals for further reporting, study, and/or possible regulation. Canada and Australia also have agencies that are well respected in assessing potential risks from chemicals.

In drawing on other parts of the world, states must be aware that these authorities can analyze the same data and come to different –and even conflicting – conclusions depending on the principles their regulatory regime is founded on. The E.U., for example, tends to take a “hazard-based” approach founded on the precautionary principle, which holds that “when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if some cause and effect relationships are not fully established scientifically” (2). The precautionary principle generally leads to more skepticism about innovative materials and technologies. As a result, the E.U. identifies chemicals as “Substances of Very High Concern” (SVHC) purely on the basis of their hazardous properties, such as being very persistent and very bioaccumulative (vPvB).

By contrast, Canada, Australia, and the U.S. have tended more towards a risk-based approach to regulation. A risk-based approach focuses not only on the theoretical potential for harm, but actual harm. If no actual harms can be measured, the action or product is allowed, and no regulatory action is taken.

Thus, a state’s choice of reference for regulating chemicals is not purely a technical matter. It is important for states to realize the different approaches to chemicals regulation at hand, and the economic consequences the approach they opt for could have. Chemicals are a sizeable industry in the U.S. economy, with total sales of $493.4 billion in 2017, according to a 2018 industry report (3).

More importantly, the approaches states take to chemicals regulation has powerful implications for jobs and economic growth in the future. The next wave of tech-based innovation will come in such physical industries as manufacturing and will be driven in part by new materials and new processes. Excessively stringent regulatory regimes or blacklisting certain chemicals will unnecessarily squelch innovations that could establish a new digital manufacturing sector that creates local jobs.

This paper will first describe how states use their limited resources to focus their chemical regulation. We will then contrast the precautionary principle with the risk-based approach, using siloxanes as an example. Specifically, as the Progressive Policy Institute wrote in a previous paper, siloxanes octamethylcyclotetrasiloxane (also known as “D4”), decamethylcyclopentasiloxane (also known as “D5”), and dodecamethylcyclohexasiloxane (also known as “D6”) have been assessed by the E.U., Canada, and Australia for their impact on human health and the environment (4). In the U.S., states such as Maine, Minnesota, and California, among others, have relied on the E.U.’s conclusions when crafting their own Chemicals of Concern lists. Contrastingly, Canada has chosen not to restrict the use of siloxanes, and other states, including Washington State and Oregon, have removed siloxanes from their lists due to the lack of evidence of real-world harm.

Finally, we will examine the economic implications of the differing regulatory approaches.

 

The Limited Resources of States

State governments simply do not have the budgetary resources to test chemicals themselves. As a result, they rely on federal or international governments to conduct the scientific research that forms the rationale for much of their health and environmental legislation and regulation. After all, why would states duplicate research that those governments have already done?

One example of this is in state Chemicals of Concern lists, where some U.S. states have imported lists of chemicals from trusted sources such as the U.S. federal government, the E.U., and Canada. For instance, Maine includes chemicals on its Chemicals of Concern list that have been listed by another authoritative governmental entity as being harmful to human health or the environment (5). These entities include the U.S. Department of Health and Human Services (HHS), Food and Drug Administration, Centers for Disease Control and Prevention, EPA, and the European Chemicals Agency, among others.

Similarly, Minnesota’s Chemicals of High Concern list was sourced by “reviewing the hazard characteristics of chemicals studied by other state, national and international agencies” (6). These agencies include Maine’s Chemicals of Concern List, the U.S. HHS, the U.S. EPA, and the European Parliament’s Authorization List under the REACH regulation (7).

California imports chemicals for its Candidate Chemicals List based on their inclusion on other authoritative lists, such as the E.U.’s substance of very high concern (SVHC) list, Canada’s Domestic Substances List, and the U.S. EPA’s Integrated Risk Information System, among others (8).

Vermont’s existing Chemicals of High Concern to Children list requires the Vermont Health Commissioner to review the list every two years to determine if additional chemicals should be added, considering “designations made by other states, the federal government, other countries, or other governmental agencies,” including the E.U.’s SVHC list (9). The state’s new legislation would make it even easier to add chemicals to the list.

Washington State uses “authoritative sources that identify chemical toxicity…and evidence of potential for exposure” to craft its Chemicals of Very High Concern to Children list.10 The authoritative sources include the U.S. EPA’s Integrated Risk Information System, the E.U.’s SVHC list, and the International Agency for Research on Cancer, among others.

And Oregon’s Health Authority uses “guidance developed by the State of Washington and other federal, state and nongovernmental organizations” to create its Chemicals of Concern for Children’s Health list (11).

 

The Risk-Based Approach vs. The Precautionary Principle

However, the importation of chemicals lists from different authoritative sources can lead to different outcomes for states, depending on the principles the regulatory regime of the authoritative source is founded on. Regulation in the E.U. tends to be rooted in a hazard-based approach that is founded on the precautionary principle, or the belief that “when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if some cause and effect relationships are not fully established scientifically” (12). This hazard-based approach is consistent with the E.U.’s skeptical approach to innovation in general.

Conversely, Canada and Australia tend to opt for a risk-based approach where all available scientific evidence is evaluated. A risk-based approach requires harms to be identified and measured. Harms can include impact to human health, the environment, or to the economy. If no harms can be identified, the product or action is permitted to continue, and no regulatory action is taken.

Take for example siloxanes, which the E.U. added to its SVHC list based on characterizing them as “persistent, bioaccumulative and toxic” (PBT) or “very persistent and very bioaccumulative:” (vPvB). Some states have drawn on the E.U.’s assessment when creating their own chemicals of concern lists (13). California includes siloxanes D4, D5, and D6 on its Candidate Chemicals List, based on the siloxanes’ presence on the E.U.’s SVHC list (14,15,16,17).

Maine uses the presence of a chemical on its Chemicals of Concern (COC) list that meets additional toxicity and exposure criteria for inclusion on its Chemicals of High Concern (CHC) list (18). As a result, D4 has been included on the state’s most recent 2015 CHC list based on the E.U.’s toxicity assessment (19). Similarly, D5 has remained on Maine’s Chemicals of Concern list based on E.U. findings. Contrastingly, D6 was removed from Maine’s COC list because of the lack of assessments by authoritative institutions (20).

In Minnesota, D4 was included on its most recent 2016 Chemicals of High Concern list based on appearing on Maine’s 2015 Chemicals of High Concern list.21 And D4 is listed on Vermont’s list of Chemicals of High Concern to Children. Like Maine, the inclusion is based on its assessment by the E.U (22).

Contrastingly, Canadian regulators initially found D4 and D5 to be harmful to the environment and, as such, both substances could possibly have been subject to regulatory measures to lessen the substances’ impact on the environment (23, 24). However, an independent review board of experts analyzed a wealth of available data, including studies that showed the real-world behavior of D5, and concluded “there is no evidence to demonstrate that Siloxane D5 is toxic to any organism tested up to the limit of solubility in any environmental matrix” (25).

In terms of D4, a government-funded environmental monitoring study, which measured real-world concentrations of D4, D5, and D6 in the environment, found very low levels of D4 in Canadian surface waters (26). Rather than restricting or banning the substance’s use in consumer or industrial products, the Canadian government required certain facilities that use D4 to implement pollution prevention plans (27).

Australian regulators came to similar conclusions when they determined that product restrictions or bans on D4, D5, and D6 were not necessary because evidence demonstrated that “[t]he direct risks to aquatic life from exposure to these chemicals at expected surface water concentrations are not likely to be significant” (28).

Similarly, some states have revised their Chemicals of Concerns lists, based on additional study by other authoritative bodies. Washington State initially included D4 on its Chemicals of High Concern to Children (CHCC) list based on its inclusion on the E.U.’s priority list for Category 1 Endocrine Disruptors. But following a detailed review of the available evidence, including a study funded by the U.S. National Institutes of Health, the Washington State Department of
Ecology concluded (30):

“D4 is present on the European Commission (EC) Category 1 list, based on a single study, showing an increase in uterine weight (McKim et al, 2007). However, a more recent study shows no effect on uterine weight by D4 (Lee et al, 2015). These mixed results, along with biomarker and in vitro data for D4 (He et al, 2003; Quinn et al, 2007; Lee et al, 2015) are not sufficient for CHCC listing…D4 is not listed by any of the other CSPA authoritative sources. D4 does not meet the CHCC listing criteria” (31).

And, because Oregon’s list is primarily sourced from Washington State’s list, Oregon also removed D4 from its High Priority Chemicals of Concern for Children’s Health list (32).

The authoritative sources that states use when crafting their own chemicals of concern lists has resulted in binary outcomes. A regulatory approach founded on precaution (such as California, Maine, and Minnesota have imported) inherently prohibits innovation. States like California, Maine, Minnesota, and Vermont, who have crafted their lists from inclusion based on the E.U.’s Category 1 Endocrine Disruptor program or SVHC lists, have taken a step toward identifying the chemicals as priority chemicals, putting siloxanes or products containing them on the road to regulation and potential ban.

Moreover, manufacturers do not want to be associated with any listed chemicals, so they stay away from them even if chemicals have not been officially banned.

For example, in Vermont, manufacturers of children’s products using chemicals of high concern to children are required to report to the state when the chemicals are used in a significant amount, and the law allows the Health Commissioner to consider banning the sale of products including the chemical (33).

In California, inclusion on the Candidate Chemicals List is an action toward listing products as a “priority product,” which would require businesses manufacturing the siloxanes to notify the California Department of Toxic Substances Control (DTSC) if their product is listed. The designation would also allow the DTSC to take other regulatory actions such as limiting the siloxanes’ use or requiring companies to replace it with an alternative (34).

Meanwhile, Washington State removed siloxanes from its list after taking a “weight of evidence” approach and analyzing all available evidence for real-world harm to human health or the environment. This approach permits advancements in innovation and growth to be realized unless evidence of real-world harm can be found.

 

Economic Implications of Chemical Regulation

The regulatory approach states take to silicones regulation has implications for jobs and economic growth not just today, but also in the future. Indeed, silicones are an input in many industries including construction, electronics, health care, household products, renewable energy technologies and personal care products, to name a few. A 2016 industry report estimated total sales of silicones products in the Americas to be $3.1 billion in 2013, with the highest consuming industries being industrial processes, construction, and personal care and consumer products (35). Restricting these materials will raise prices for both manufacturers and the industries that utilize silicones.

What’s more, the rebirth of manufacturing jobs in the U.S. will rely on new technologies such as 3D printing, which themselves rest on the creation of new and reformulated materials. As the Progressive Policy Institute (PPI) pointed out in a 2018 paper, “the range of materials that can be 3D printed is constantly expanding. Desktop Metal is expected to come out with a metal 3D printing system for mass production in 2019. HP plans to launch a line of 3D printers that produce metal objects, an expansion from the company’s existing 3D printers that produce plastic-based products” (36).

Take German chemical company Wacker Chemie for example, who in 2016 discovered how to 3D print silicones, a process that requires heating and binding a material that is naturally heat-resistant to manufacture goods (37). This innovation will open up new markets for manufacturers in critical areas of application such as medicine, where silicone is considered to be bio-compatible and durable. Silicone 3D printing also enables manufacturers to cut production costs, become more efficient, and enable new business models upon which new U.S. manufacturing jobs would be based.

New and reformulated materials will also be needed to revitalize the construction sector, where productivity growth has lagged and the cost of construction has doubled since 2000, as PPI wrote in a 2017 report (38). One of the contributors to rising prices in the sector was the cost of materials, as certain asphalt products, paving mixtures, and steel products are nearly twice as expensive today as they were in 2000. Innovation in materials would help revitalize productivity and economic growth in the sector.

If states move to blacklist or even prohibit silicones based on the E.U.’s lists rooted in the precautionary principle rather than on real-world scientific evidence, that is not a good sign for the regulatory attitude toward new materials with less of a track record.

Indeed, the broader danger is that a strict precautionary approach to chemical listing
and regulation, as would be implied by tighter regulation of silicones, would have negative implications for the rebirth of manufacturing jobs in the U.S. After all, under states importing lists from the E.U., the companies that manufacture and use new materials would have to be able to conclusively prove their lack of impact on human health and the environment in order to continue using them.

 

Conclusion

State governments do not have the budgetary resources to test or evaluate chemicals themselves. As a result, they rely on national and international governments to conduct the research and assessments that form the basis of health and environmental regulation. But, depending on the underlying principles of the authoritative source’s regulatory regime, states could end up with different conclusions.

Siloxanes provide a prime example of these differences in approach. The E.U. has designated them as substances of very high concern and have moved to restrict the use of silicones in certain products, based on being “very persistent and very bioaccumulative.” By contrast, Canada and Australia have taken a weight of evidence approach, analyzing all the available evidence and requiring real-world harm to the environment or human health before taking regulatory action.

The result has led to different outcomes. While states relying on the E.U.’s SVHC list and related criteria have put D4, D5, and D6 on a path to regulation, states that have taken a weight-of-evidence approach similar to Canada and Australia have removed silicones from their Chemicals of Concern list and allowed the silicones unrestricted in the marketplace. If states are to develop Chemicals of Concern lists at all, state policymakers should consider basing those lists only on authorities that evaluate chemicals utilizing a risk-based approach. This would decrease instances where substances that pose little or no risk, like siloxanes, are blacklisted unnecessarily.

These divergent outcomes have implications for jobs and economic growth today and in the future. Silicones are a multi-billion-dollar industry in the Americas and an input in many goods and services, including industrial processes, construction, healthcare, and personal care and consumer products.

What’s more, the rebirth of manufacturing jobs in the U.S. will rely on new technologies such as 3D printing, which themselves require the creation of new and reformulated materials. Silicones will play a critical role in realizing new materials that will revitalize other industries such as manufacturing and construction, where productivity and job growth has lagged for years.

Indeed, precautionary regulation of silicones by states, rather than risk-based, does not indicate regulators are prioritizing innovation. Rather, it signals negative implications for the revitalization of historically important industries to the U.S. economy.

 

REFERENCES

1) Michael Mandel, “The Trade War Spreads to Mexico, And The Window Opens Wider for Digital Manufacturing,” https://www.forbes.com/sites/michaelmandel1/2019/05/31/the-trade-war-spreads-to-mexico-and-the-window-opens-wider-for-digital-manufacturing/#27a94a784589

2) “Wingspread Conference on the Precautionary Principle,” Science and Environmental Health Network, January 26, 1998.

3) “2018 Elements of the Business of Chemistry,” American Chemistry Council. https://www.americanchemistry.com/2018-Elements-of-the-Business-of-Chemistry.pdf

4) Elliott Long and Michael Mandel, “Science-based Regulation and Innovation: The Silicone Example,” Progressive Policy Institute, May 2018. https://www.progressivepolicy.org/wp-content/uploads/2018/05/PPI_Silicones-Paper-2018.pdf

5) “Chemicals of High Concern Triennial Update Documentation,” Maine Center for Disease Control and Prevention, July 21, 2015.

6) “Toxic Free Kids Act: Chemicals of High Concern – Frequently Asked Questions,” Minnesota Department of Health, July 2010. https://www.health.state.mn.us/communities/environment/childenvhealth/tfka/faq.html#how

7) “Minnesota Chemicals of High Concern List Methodology,” Minnesota Department of Health, July 1, 2010. https://www.health.state.mn.us/communities/environment/childenvhealth/docs/chlist/methodology.pdf

8) “§ 69502.2. Candidate Chemicals Identification,” California Department of Toxic Substances Control. https://dtsc.ca.gov/wp-content/uploads/sites/31/2018/10/69502-2-Candidate-Chemicals-Identification.pdf

9) “No. 188. An act relating to the regulation of toxic substances, §1773.” Vermont Department of Health. https://www.healthvermont.gov/sites/default/files/documents/2016/11/Env_CDP_ACT188_0.pdf

10) “Children’s Safe Products Reporting Rule Rationale for Reporting List of Chemicals of High Concern to Children 2011-2017,” State of Washington Department of Ecology, November 2018. https://fortress.wa.gov/ecy/publications/documents/1804025.pdf

11) “S.B. 478, the Toxic Free Kids Act,” 78th Oregon Legislative Assembly – 2015 Regular Session. https://olis.leg.state.or.us/liz/2015R1/Downloads/MeasureDocument/SB478

12) “Wingspread Conference on the Precautionary Principle,” Science and Environmental Health Network, January 26, 1998.

13) Regulation (Ec) No 1907/2006 Of The European Parliament And Of The Council

14) “Candidate Chemicals List,” California Department of Toxic Substances Control. https://dtsc.ca.gov/scp/authoritative-lists/

15) “Octamethylcyclotetrasiloxane (D4),” California Department of Toxic Substances Control. https://calsafer.dtsc.ca.gov/cms/candidate-chemical/?rid=21382&from=search

16) “Decamethylcyclopentasiloxane (D5),” California Department of Toxic Substances Control. https://calsafer.dtsc.ca.gov/cms/candidate-chemical/?rid=21353&from=search

17) “Dodecamethylcyclohexasiloxane (D6),” California Department of Toxic Substances Control. https://calsafer.dtsc.ca.gov/cms/candidate-chemical/?rid=21352&from=search

18) “Chemicals of High Concern Triennial Update Documentation,” Maine Center for Disease Control and Prevention, July 21, 2015.

19) “Chemicals of High Concern 2015 Triennial Update,” Maine Center for Disease Control and Prevention, July 21, 2015.

20) Kyle Brown, “Silicone regulations evolve globally,” Rubber & Plastic News, April 30, 2018. https://www.rubbernews.com/article/20180430/NEWS/180509999/silicone-regulations-evolve-globally

21) “The 2016 Minnesota Chemicals of High Concern List,” Minnesota Department of Health. https://www.health.state.mn.us/communities/environment/childenvhealth/docs/chlist/mdhchc2016.pdf

22) “Octamethylcyclotetrasiloxane (D4),” Vermont Department of Health. https://www.healthvermont.gov/sites/default/files/documents/pdf/ENV_CDP_556_67_2_Octamethylcyclotetrasiloxane.pdf

23) “Siloxane D4 (Cyclotetrasiloxane, octamethyl-),” Government of Canada. https://www.canada.ca/en/health-canada/services/chemical-substances/challenge/batch-2/cyclotetrasiloxane-octamethyl.html

24) “Siloxane D5 (Cyclopentasiloxane, decamethyl-),” Government of Canada. https://www.canada.ca/en/health-canada/services/chemical-substances/challenge/batch-2/cyclopentasiloxane-decamethyl.html

25) “Report of the Board of Review for Decamethylcyclopentasiloxane (Siloxane D5),” Environment and Climate Change Canada. https://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=515887B7-1&offset=7&toc=show

26) De-Gao Wang, Helena Steer, Tara Tait, Zackery Williams, Grazina Pacepavicius, Teresa Young, Timothy Ng, Shirley Anne Smyth, Laura Kinsman, and Mehran Alaee. “Concentrations of cyclic volatile methylsiloxanes in biosolid amended soil, influent, effluent, receiving water, and sediment of wastewater treatment plants in Canada,” Chemosphere, November 2012.

27) “Siloxane D4 in industrial effluents: pollution prevention planning notice,” Environment and Climate Change Canada. https://www.canada.ca/en/environment-climate-change/services/pollution-prevention/planning-notices/performance-results/siloxane-d4-industrial-effluents-overview.html

28) https://www.nicnas.gov.au/chemical-information/imap-assessments/imap-assessments/tier-ii-environment-assessments/cvms

29) “Children’s Safe Products Reporting Rule: Rationale for Reporting List of Chemicals of High Concern to Children 2011-2017,” State of Washington Department of Ecology, November 2018. https://fortress.wa.gov/ecy/publications/documents/1804025.pdf

30) Lee D, Ahn C, An BS, Jeung EB. (2015) Induction of the estrogenic marker calbindn-d9k by octamethylcyclotetrasiloxane. Int J Environ Res Public Health 12:14610-25. https://www.ncbi.nlm.nih.gov/pubmed/14575643

31) “Concise Explanatory Statement, Chapter 173-334 WAC, Children’s Safe Products Reporting Rule: Summary of rulemaking and response to comments,” State of Washington Department of Ecology, September 2017. https://fortress.wa.gov/ecy/publications/documents/1704034.pdf

32) “U.S. – Oregon Amends Toxic-Free Kids Rule,” Intertek, October 02, 2018. https://www.intertek.com/consumer/insight-bulletins/oregon-amends-toxic-free-kids-rule/

33) “Safer Chemicals in Children’s Products Rules: Regulation of Chemical Use in Children’s Products: Chapter 880,” Maine Department of Environmental Protection. https://www.maine.gov/dep/safechem/rules.html

34) “How Do the Priority Products Affect Me?,” California Department of Toxic Substances Control. https://dtsc.ca.gov/scp/how-do-the-priority-products-affect-me/

35) “Socio-economic evaluation of the global silicones industry: regional summary – the Americas,” Global Silicones Council, March 2016. https://sehsc.americanchemistry.com/Socio-Economic-Evaluation-of-the-Global-Silicones-Industry-The-Americas.pdf

36) Michael Mandel, “The Rise of the Internet of Goods: A New Perspective on the Digital Future for Manufacturers,” MAPI Foundation and Progressive Policy Institute, August 7, 2018. https://www.progressivepolicy.org/wp-content/uploads/2018/08/Internetofgoods-reportPPI-2018 .pdf

37) “Silicone 3D Printer – All You Need to Know in 2019,” All3DP.com. https://all3dp.com/2/silicone-3d-printer-all-you-need-to-know/

38) Elliott Long, “Soaring Construction Costs Threaten Infrastructure Push,” Progressive Policy Institute, October 2017. https://www.progressivepolicy.org/wp-content/uploads/2017/10/PPI_Construction_2017.pdf

Marshall for Medium: “Trump’s Biggest Broken Promise”

Unlike such polarizing issues as health care, immigration and climate change, repairing and updating our economic infrastructure is something both parties say they are for. Yet somehow our political leaders can’t get the job done.

President Trump often complains about the shabby state of America’s airports, highways and railways. “The only one to fix the infrastructure of our country is me — roads, airports, bridges,” he tweeted just before launching his 2016 presidential bid. “I know how to build, pols only know how to talk!”

Yet Trump’s lack of focus and discipline, along with his clownish political antics, keep sabotaging bipartisan progress on infrastructure. In a meeting with House Speaker Nancy Pelosi and Senate Democratic leader Chuck Schumer in April, Trump proposed to spend $2 trillion on infrastructure. But the deal quickly unraveled as Republican Senators made clear they wouldn’t support gas or other tax increases to pay for it.

 

Read the full piece on Medium by clicking here. 

Bledsoe for Forbes: “Tax Credits for Affordable Electric Vehicles Gain Speed, But Legislation Must Avoid Stop Signs

As Congress begins to turn toward tax policies to help clean energy manufacturing, electric vehicle tax credits aimed directly at more affordable vehicles are gaining speed, just as a previous Forbes column and a Progressive Policy Institute (PPI) white paper urged several months ago.

The question now is will EV advocates in Congress, the U.S. auto industry and labor unions get the message and reform tax incentives to benefit middle-income Americans. Such revised tax credits focused on more affordable EVs will increase the chances new incentives become law, and will better allow the U.S. to reap the remarkable economic, health, manufacturing and environmental benefits of EVs. Yet as of now, new EV tax credits have been left entirely out of a so-called “tax extenders” outline circulating among House Ways and Means Committee members.

But a series of new developments are demonstrating that tax credits focused on affordable vehicles are gaining momentum.

 

Read the full piece on Forbes by clicking here. 

Valentine for Washington Informer: “Recognizing Donald Hense”

The African American community’s fight for quality education is a 12-months-a-year struggle, and every month — not just Black History Month — is a great time to reflect on what’s working and who is successful in fighting for quality public education in our community. Donald Hense and the Friendship Charter Network are worthy of recognition.

Hense is founder and board chairman of the Friendship Charter Network, the largest African American-led charter school network in America. Hense’s accomplishment is significant, because, while over 80 percent of charter school students are Black or Latino, fewer than 10 percent of charter schools are founded and led by Blacks or Latinos, according to a study by the Brookings Institute.

Read Curtis’ full piece here.

Kim for Medium: “The Dismal State of America’s Working Class”

President Donald Trump staked his successful claim to the U.S. presidency with his appeal to the discontents of blue-collar America — i.e., non-college-educated Americans who have perhaps been the hardest hit by globalization and technological change.

The same voters are the target of some of Trump’s Democratic 2020 challengers, most notably former Vice President Joe Biden. Biden, for instance, launched his campaign in a Pennsylvania union hall, declaring himself to be “a union man, period.”

Both Biden and Trump are right to focus their attentions on this group of Americans, whose fortunes have not risen with the overall economy but stagnated or even fallen. Without the benefit of higher education, working class Americans have been unable to compete for jobs demanding specialized technical skills, while the places they live have been hollowed out by shifts in global supply chains and the death of low-skilled manufacturing. So long as these workers feel left out of the economic mainstream, they will remain a potent political force, including in the upcoming 2020 election.

Read the full piece on Medium by clicking here. 

Gerwin for Medium: “Getting Democrats to ‘Yes’ on Trump’s New NAFTA”

President Trump is apparently a trade alchemist. He’s taken the core of NAFTA (the “worst trade deal ever”), liberally sprinkled in modern rules from the Trans Pacific Partnership (a “potential disaster”), and created a “brand new” trade deal — the US-Mexico-Canada Agreement (USMCA).

Trump’s hyperbole aside, the USMCA, while not perfect, would do a creditable job of preserving the essential rules of the road for North America’s highly integrated, $22 trillion economy. It would also update the decades-old NAFTA by, among other things, adding enforceable labor and environmental rules, promoting digital commerce, and cutting red tape for small business. Given Trump’s years of railing against NAFTA and repeated threats to terminate the Agreement, this is a positive development.

For the USMCA to enter into force, it must be approved by Congress, including the Democratic-controlled House. In recent weeks, Trump hasn’t been helping this process. Insulting and trying to bulldoze House Democratic leaders and threatening damaging new tariffs on Mexico are hardly constructive strategies.

 

Read the full piece on Medium by clicking here.  

Joe Biden and Amazon

Progressives say that they want Corporate America to think long-term rather than short-term: To invest in research and development, to spend more on domestic plant and equipment, and to hire more workers with decent pay and decent benefits. In fact, we’ve designed the tax system specifically to give companies incentives to do that.

That’s why Joe Biden should be applauding Amazon rather than criticizing it. In a tweet on Thursday, Biden wrote: “I have nothing against Amazon, but no company pulling in billions of dollars of profits should pay a lower tax rate than firefighters and teachers. We need to reward work, not just wealth.”

But if there’s any company that’s about investing in America and American workers, it’s Amazon. Amazon was #3 in our 2017 list of the top companies ranked by U.S. capital spending, putting $12 billion into the U.S. economy that year alone. Because of the productivity gains from these investments, the company was able to institute a $15 minimum wage for all full-time, part-time and temporary workers, covering even low-wage states like Tennessee, where the hourly median wage for all workers is less than $17. The productivity gains have also sent the stock price soaring, putting billions of taxable dollars into the hands of Amazon employees in the form of restricted stock units. And Amazon funnels back billions of dollars each year in long-run R&D spending.

The federal tax system is intentionally designed to reward this type of corporate behavior and strong performance. For example, the 2017 changes to the tax code allow a company like Amazon to deduct much of its capital spending from its taxable income right away, lowering its tax bill. R&D spending gets a sizable tax credit from the federal government as well. And the rules covering the exercise of stock grants, while lowering Amazon’s tax bill, could be generating a great deal of personal tax revenue for the government.

Here’s why: A stock grant—which were given to many Amazon employees, and not just the top ranking executives—is more valuable the higher the stock goes. When the employee is granted stock, it is generally taxed by the government as ordinary income. Meanwhile, part of that cash is deducted from the company’s income, just like any other worker pay, lowering the company’s taxable income. In other words, the more successful the company is, in terms of a rising stock price, the more money flows to employees. And the more money that flows to employees, the more taxes are paid by the employees as personal taxes rather than corporate taxes.

So it’s not surprising that a successful company like Amazon that is investing in America is going to have a lower tax rate than workers—the tax system is designed that way. Conversely, a company that is not investing in R&D or capital spending, and has a falling stock price, may be paying a bigger share of its income in taxes—but is it really benefiting Americans?

Progressives may not be satisfied with everything that Amazon is doing. But Biden and other Democrats shouldn’t blame Amazon for investing in America, and then following the rules of a tax system that is specifically designed to encourage corporate investment. It’s good for workers and consumers.

 

PPI Previews Blueprint for Funding America’s Future at Fiscal Summit

For the past eight months, PPI’s Center for Funding America’s Future has been developing a fiscal blueprint that would restore America’s commitment to public investment, rebalance the intergenerational compact for 21st-century demographics, and implement pro-growth tax reform that rewards work over wealth. We previewed the plan yesterday at the Peter G. Peterson Foundation’s 10th annual fiscal summit, which convenes economists and policymakers from across the political spectrum to discuss our nation’s fiscal challenges. Six other think tanks also presented their own budget proposals (which can be found here) at the summit: American Action Forum, American Enterprise Institute, Bipartisan Policy Center, Center for American Progress, Manhattan Institute, and Economic Policy Institute.

All seven groups produced plans that would put the national debt on a more sustainable trajectory than it is on under current law, with PPI’s plan achieving the second-largest amount of long-term debt reduction. But even more importantly, we created a unique and innovative blueprint that would once again make fiscal policy an instrument of economic and social progress.

When summarizing the plans, former Acting Director of the Congressional Budget Office Barry Anderson – who helped ensure the plans were being scored using similar methodologies – noted that PPI’s blueprint included the most funding for non-defense discretionary spending. NDD is the category of federal spending that includes most public investments in education, infrastructure, and scientific research. PPI’s blueprint increases funding for these investments that lay the foundation for long-term economic growth by more than 70 percent over current projections. This approach is consistent with a message echoed by the overwhelming majority of summit participants throughout the day: the United States is spending too much on consumption by the present generation and not enough on investment in the next.

The biggest difference among the groups was our approach to health care. Groups on the left proposed to put most or all Americans on government-run health insurance programs, which would give the federal government outsized ability to demand lower prices from providers. Groups on the right, meanwhile, proposed to bet on the private sector’s ability to contain health care costs through increased competition through reforms such as premium support for Medicare. PPI proposed to take the best of both approaches through a default-price health care system, under which the federal government would set benchmark prices but all allow private insurers to continue pursuing innovative ways to finance and manage care in a competitive market.

PPI also pursued a unique approach to reforming Social Security. Whereas most other groups proposed to raise payroll taxes on workers, PPI proposed to repeal the payroll tax entirely and fund the program through other revenue sources. Some groups on the right proposed to give everyone the same Social Security benefit regardless of their earnings history, while most other groups retained the current program structure (in which benefits are awarded based on a beneficiary’s 35 highest-earning years). Under a more egalitarian benefit formula developed by PPI, individuals would earn a flat “work credit” for each year they spent in the workforce regardless of what they were paid, meaning a low-skilled worker and their college-educated boss would receive the same benefit in retirement if they work hard for the same number of years.

Representatives from the other participating think tanks praised elements of this structure during a panel discussion, such as our decision to allow workers to earn up to five years of work credits for time taken out of the workforce to serve as a caregiver. We were also commended for our proposals to protect the economy from future recessions, which included automatic adjustments in spending on public investment and unemployment benefits when growth slows. Additionally, PPI proposed the creation of a dynamic value-added tax, which would be a consumption tax with a standard rate of 15 percent that automatically adjusts downward during recessions (and rises back up following recoveries). These policies together would stimulate demand and consumption when the economy needs it most.

Another PPI tax proposal that received praise was our recommendation to change the primary financing mechanism for highways in the United States from a tax on gasoline, which has been eroded by inflation and rising fuel efficiency, to a tax on vehicle-miles traveled. Nearly all groups, including PPI, agreed that the United States should adopt a carbon tax and repeal step-up basis for taxing inheritances, which allows wealthy investors to pass assets on to their heirs without anyone ever paying taxes on capital gains.

Next month, PPI will publish a full report with more-detailed recommendations than what we were able to present at the summit. In the interim, we thoroughly enjoyed this opportunity to discuss the ideas proposed by all seven participating organizations and promote our vision for a fiscally responsible progressivism that invests in our future without leaving the bill to young Americans. We also enjoyed hearing House Speaker Nancy Pelosi champion her commitment to a similar vision earlier in the day and hope she and the new majority can draw upon our recommendations to create a more prosperous and fiscally sustainable future for all Americans.

View Full Article Here:

Blog: The Luddite Attitude of San Francisco Supervisors on Vaping is Anti-Science and Regressive

2020 will mark the 100-year anniversary of alcohol Prohibition in the United States – a flawed experiment that lasted for 13 years before being repealed.

The city of San Francisco is about to ignore the lessons of this disastrous experiment, and vote to ban all sales and access to vaping products.  But unlike Prohibition, which banned all alcohol, San Francisco’s effort isn’t banning all tobacco products. Rather, the City will continue to allow access to the most harmful use of tobacco, combustible cigarettes.

It’s a very odd message to send:  please use carcinogen-laden products that will kill you faster, but by all means, DON’T touch a product that will improve your health and the health of those around you.

Forty million Americans still smoke traditional cigarettes today.  That’s after 25 years of aggressive anti-smoking campaigns, tax increases and 10 years of FDA oversight of nicotine.  These adult smokers clearly are not going to quit, and the choice of policymakers is to either wait for the 40 million to die or embrace innovation and science to help these smokers and those around them by providing access to new technologies.

As a progressive and adult smoker, I choose the latter and staunchly believe we must give adults an off-ramp from using combustible tobacco.

Policymakers have a responsibility to address access to all nicotine products for young people. No teenager should be permitted to buy, try, test, or experiment with any nicotine delivery device. California has a law that already states that you must be 21 or over to purchase tobacco. That is an appropriate and pragmatic policy.

The science is clear: every adult smoker who switches to a new product like vape or “heat not burn” and away from combustible tobacco is reducing the harmful intake by up to 98%.  If all 40 million American smokers switched to these products today, their health would improve, the health of those around them would improve, and our health care costs would be reduced.

These outcomes are not only impressive—they are utterly achievable if we choose to provide age-appropriate adult smokers access to a variety of products. Unfortunately, if you live in San Francisco, the City Supervisors current efforts support one mantra: burn tobacco until you die.

Meanwhile, our friends around the globe are embracing innovation. In Japan in just a few short years they have been able to switch 33% of combustible smokers to heat not burn users.  In the United Kingdom, the government runs public service announcements encouraging adult smokers to switch to these less harmful products.

The Royal College of Physicians makes it pretty clear: “Large-scale substitution of e-cigarettes, or other non-tobacco nicotine products, for tobacco smoking has the potential to prevent almost all the harm from smoking in society. Promoting e-cigarettes, [Nicotine Replacement Therapy] and other non-tobacco nicotine products as widely as possible, as a substitute for smoking, is therefore likely to generate significant health gains in the UK”

The city leaders who will vote on this ban should ask themselves if adult smokers deserve a chance at living a better, healthier and longer life by using and embracing innovation, or continuing to suffer the ill effects of burning tobacco.  San Francisco is supposed to be a modern-day Mecca of innovation, a hub of the progressive spirit and forward-looking leadership. In a city known worldwide for its ability to change the world, this ban is a regressive move that ignores data, science and the well-being of citizens.

Bledsoe for The Hill: “Biden’s domestic climate plan is good, but his global strategies are crucial”

As many climate activists had hoped, Democratic presidential front-runner Joe Biden came forward this week with an ambitious domestic climate change plan that proposes to cut U.S. emissions deeply while growing America’s clean energy sector.

Yet, as important as the domestic elements of Biden’s plan and those of his rivals are, they are ultimately most valuable ecologically in legitimizing the key international aspects of climate protection, which are crucial to solving the inherently global nature of the climate problem in the first place.

After all, U.S. greenhouse gas emissions are only about 15 percent of the world total, compared to 30 percent from China alone. Fortunately, the E.U., U.S., China and fewer than 10 of other nations account for well over 80 percent of global emissions, meaning targeted international efforts have strong potential to reach the lion’s share of the problem.

Credible U.S. domestic climate action is a precondition to gaining the trust and respect of the rest of the world — and allowing America to exert unique pressure on other major nations to cut their emissions.

Read the full piece here.

Marshall for The Hill: “Our love-hate relationship with ‘Big Tech'”

Politicians on both sides of the Atlantic are drawing a bead on big U.S. tech companies. Sen. Elizabeth Warren (D-Mass.) says they have grown too powerful and calls for breaking them up — a stance that’s rapidly become a new liberal litmus test.

Meanwhile, European regulators have been slapping stiff fines on Facebook, Google and Apple for a variety of alleged misdeeds, ranging from tax avoidance to privacy and copyright violations.

President Trump has stirred the pot by claiming that social media companies’ efforts to purge their platforms of false and hateful content are biased against conservatives. The Justice Department, Federal Trade Commission and House Democrats are all gearing up probes into alleged anti-competitive behavior by the tech giants.

Read the full piece here.

The Price of Innovative and Effective Treatments

Here’s a question that progressives should be asking themselves: How can we encourage the development of innovative and effective treatments like Zolgensma?

Just approved by the FDA, Zolgensma is a powerful new treatment for Spinal Muscular Atrophy (SMA), which is the leading genetic cause of death in infants and toddlers. Roughly one out of every 50 adults carries one copy of the defective gene that causes SMA, and the disease affects roughly one out of every 6,000-10,000 live births.

Zolgensma—developed and marketed by AveXis, now part of Novartis—is given as a single intravenous infusion that delivers a working copy of the defective gene to motor neurons, heading off the debilitating effects of SMA. Based on the clinical trials, the positive effects of the infusion seem to persist for years.

In fact, Zolgensma is only the second gene therapy approved in the U.S. for commercial use. Since the 1970s, medical scientists have been fascinated by the idea of curing genetic diseases by modifying cell genes. However, getting to this point has been a long and winding road, punctuated by expensive setbacks and dead-ends.

Zolgensma’s success points the way to a coming future of cures and innovative treatments for debilitating diseases. That could be a triple win for progressives: Health care outcomes would improve; the long-term resource costs of healthcare to society would fall; and offering quality health care to everyone would be cheaper and easier.

But then comes the sticker shock: AveXis and Novartis are setting an initial price of $2.1 million for the one-dose treatment. For people concerned about the cost of health care, this seems like a ridiculous number.

I don’t want to get into the question of what the “right” price of the treatment should be. But based on the current medical and human cost of SMA, $2.1 million is not as big as it seems. Without a drug treatment, “best supportive care” for infantile onset SMA costs $800,000, and only yields 2.4 life-years, and less than 0.5 quality-adjusted life years (QALY). That’s according to ICER, an independent research institute.

By comparison, giving Zolgensma to pre-symptomatic infants with SMA—a usage that the FDA has approved—could give them 27 life-years and 22 QALYs, according to ICER.* How much would you pay for 25 extra years of life?

Of course, we also have to figure in how much additional medical and nursing care an infant with SMA and treated with Zolgensma will need over time. That needs to be taken into account as well.

It should be noted the initial high price of a gene therapy like Zolgensma, when introduced, may not last long. Competition from other medicines is likely to push down the price. Roche, for example, is planning to submit a new drug for treating SMA to the FDA later in 2019. In addition, AveXis and Novartis will set up 5-year payment plans for states, small insurance firms, and self-insured employers, and provide rebates if the treatment is not successful.

Many people complain that corporations take a short-term perspective and don’t take risks for the future. The truth is, for the past forty years research and development into gene therapy has been one of the best ways for the pharma and biotech sectors to lose money, since the first treatment was only approved for commercial use in 2017.

In the end, progressives who want a better-functioning and fairer healthcare system should also want as many cures and innovative and effective treatments on the market as quickly as possible. That means giving pharma and biotech companies the incentive to take the necessary risks.


*The ICER report was released before the FDA approval. But ICER analyzed what they called “Drug X,” which was the equivalent of Zolgensma given to pre-sympomatic infants.

 

Kim for Medium: “Being a moderate in Congress is expensive”

Few jobs in politics might be tougher than to be a moderate member of Congress. Moderates typically hail from competitive districts, which means they enter office with targets on their backs from an opposition eager to wrest away their seats. And unlike their colleagues in safely blue or red seats, they must juggle the concerns of a diverse constituency, meaning less room to embrace the kinds of ideas that appeal to an activist base.

Moderates’ vulnerability also inevitably means a greater burden when it comes to campaign fundraising. In 2018, for instance, moderate Democratic candidates who won their campaigns spent twice as much as winning candidates from more liberal, comfortably blue districts. Moderates, in other words, literally paid the price for Democrats’ majority — a fact the progressive left should keep in mind as the 2020 election approaches.

Read the full piece on Medium by clicking here.